Prader Willi Syndrome Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Prader-Willi Syndrome Pipeline Insight 2024" report provides comprehensive insights about 18+ companies and 18+ pipeline drugs in Prader-Willi Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Explore our latest breakthroughs in Prader Willi Syndrome Research. Learn more about our innovative pipeline today! @ Prader Willi Syndrome Pipeline Outlook- https://www.delveinsight.com/sample-request/prader-willi-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Prader Willi Syndrome Pipeline Report
• In November 2024:- Harmony Biosciences LLC- A Phase 3, Randomized, Double-Blind, Placebo-controlled, Efficacy and Safety Study of Pitolisant Followed by an Open-Label Extension in Patients with Prader-Willi Syndrome. The study will consist of an up to 45-day Screening/Baseline Period, a Double-Blind Treatment Period, and an optional Open-Label Extension Period.
• In November 2024:- ACADIA Pharmaceuticals- A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome. This is a 12-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study comparing carbetocin nasal spray 3.2 mg TID with placebo (matched placebo nasal spray TID) in subjects with PWS.
• DelveInsight's Prader Willi Syndrome pipeline report depicts a robust space with 18+ active players working to develop 18+ pipeline therapies for Prader Willi Syndrome treatment.
• The leading Prader Willi Syndrome Companies such as Soleno Therapeutics, Levo Therapeutics, Inversago Pharma, Saniona, LG Life Sciences, GLWL Research, OptiNose, Larimar Therapeutics, Helsinn, ConSynance Therapeutics, Neuren Pharmaceuticals, Radius Health, Rhythm, Tonix Pharmaceuticals, and others.
• Promising Prader Willi Syndrome Therapies such as DCCR, ARD-101, Carbetocin, and others.

Stay informed about the cutting-edge advancements in Prader Willi Syndrome treatments. Download for updates and be a part of the revolution in care @ Prader Willi Syndrome Clinical Trials Assessment- https://www.delveinsight.com/sample-request/prader-willi-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Prader Willi Syndrome Emerging Drugs Profile

• Diazoxide choline controlled release (DCCR): Soleno Therapeutics
Diazoxide choline controlled-release tablet is a novel, proprietary extended-release, crystalline salt formulation of diazoxide, which is administered once-daily. The parent molecule, diazoxide, has been used for decades in thousands of patients in a few rare diseases in neonates, infants, children and adults, but has not been approved for use in PWS. Soleno conceived of and established extensive patent protection on the therapeutic use of diazoxide and DCCR in patients with PWS. The DCCR development program is supported by data from five completed Phase I clinical studies in healthy volunteers and three completed Phase II clinical studies, one of which was in PWS patients. In the PWS Phase II study, DCCR showed promise in addressing hyperphagia, the hallmark symptom of PWS, as well as several other symptoms such as aggressive/destructive behaviors, fat mass and abnormal lipid profiles. It is currently in phase III stage of development.

• Intranasal carbetocin (LV-101): Levo Therapeutics
Intranasal carbetocin is similar to the naturally-occurring hormone oxytocin, but with greater selectivity for the effect of interest - stimulation of oxytocin receptors. These receptors are involved in the regulation of both social-emotional and feeding behaviors. In July 2022, company announced that the U.S. Food and Drug Administration (FDA) had granted Priority Review for its New Drug Application (NDA) for LV-101 (intranasal carbetocin) as a treatment for hyperphagia and behavioral distress associated with PWS.

Learn more about Prader Willi Syndrome Drugs opportunities in our groundbreaking Prader Willi Syndrome Research and development projects @ Prader Willi Syndrome Unmet Needs- https://www.delveinsight.com/sample-request/prader-willi-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Prader Willi Syndrome Companies
Soleno Therapeutics, Levo Therapeutics, Inversago Pharma, Saniona, LG Life Sciences, GLWL Research, OptiNose, Larimar Therapeutics, Helsinn, ConSynance Therapeutics, Neuren Pharmaceuticals, Radius Health, Rhythm, Tonix Pharmaceuticals, and others.

Prader-Willi Syndrome pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical.
• Molecule Type

Prader Willi Syndrome Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
• Product Type

Discover the latest advancements in Prader Willi Syndrome treatment by visiting our website. Stay informed about how we're transforming the future of disease @ Prader Willi Syndrome Market Drivers and Barriers, and Future Perspectives- https://www.delveinsight.com/sample-request/prader-willi-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Prader Willi Syndrome Pipeline Report
• Coverage- Global
• Prader Willi Syndrome Companies- Soleno Therapeutics, Levo Therapeutics, Inversago Pharma, Saniona, LG Life Sciences, GLWL Research, OptiNose, Larimar Therapeutics, Helsinn, ConSynance Therapeutics, Neuren Pharmaceuticals, Radius Health, Rhythm, Tonix Pharmaceuticals, and others.
• Prader Willi Syndrome Therapies- DCCR, ARD-101, Carbetocin, and others.
• Prader Willi Syndrome Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Prader Willi Syndrome Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

For a detailed overview of our latest research findings and future plans, read the full details of Prader Willi Syndrome Pipeline on our website @ Prader Willi Syndrome Emerging Drugs and Companies- https://www.delveinsight.com/sample-request/prader-willi-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Introduction
2. Executive Summary
3. Prader-Willi Syndrome: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Late Stage Products (Phase III)
7. Diazoxide choline controlled release (DCCR): Soleno Therapeutics
8. Drug profiles in the detailed report…..
9. Mid Stage Products (Phase II)
10. Tesomet: Saniona
11. Drug profiles in the detailed report…..
12. Early Stage Products (Phase I)
13. INV 101: Inversago Pharma
14. Drug profiles in the detailed report…..
15. Preclinical and Discovery Stage Products
16. TNX-2900: Tonix Pharmaceuticals
17. Drug profiles in the detailed report…..
18. Inactive Products
19. Prader-Willi Syndrome Key Companies
20. Prader-Willi Syndrome Key Products
21. Prader-Willi Syndrome- Unmet Needs
22. Prader-Willi Syndrome- Market Drivers and Barriers
23. Prader-Willi Syndrome- Future Perspectives and Conclusion
24. Prader-Willi Syndrome Analyst Views
25. Prader-Willi Syndrome Key Companies
26. Appendix

List of Highly Demanded Research Reports in 2024

cxcr inhibitors market: https://www.delveinsight.com/report-store/selective-inhibitor-of-the-cxcr4-chemokine-receptor-market-forecast
fertility monitoring devices market: https://www.delveinsight.com/report-store/fertility-monitoring-devices-fertility-testing-devices-market
ornithine transcarbamylase deficiency market: https://www.delveinsight.com/report-store/ornithine-transcarbamylase-deficiency-otc-deficiency-market
orthopedic power devices market: https://www.delveinsight.com/report-store/orthopedic-power-devices-market
otitis media market: https://www.delveinsight.com/report-store/otitis-media-market
persistent depressive disorder market: https://www.delveinsight.com/report-store/major-depressive-disorder-market
smoking cessation market: https://www.delveinsight.com/report-store/smoking-cessation-market
surgical sealant market: https://www.delveinsight.com/report-store/surgical-sealant-and-adhesives-market
urothelial carcinoma market: https://www.delveinsight.com/report-store/urothelial-carcinoma-market
vascular grafts market: https://www.delveinsight.com/report-store/vascular-grafts-market
vital sign monitors devices market: https://www.delveinsight.com/report-store/vital-sign-monitors-external-remote-patient-monitoring-devices-market
aplastic anemia market: https://www.delveinsight.com/report-store/aplastic-anemia-market
cart pipeline: https://www.delveinsight.com/report-store/car-t-pipeline-insight
celiac disease market: https://www.delveinsight.com/report-store/celiac-disease-cd-market
coronary stents market: https://www.delveinsight.com/report-store/coronary-stents-market-market
diabetic gastroparesis market: https://www.delveinsight.com/report-store/diabetic-gastroparesis-market-size
elastomeric pump market: https://www.delveinsight.com/report-store/elastomeric-pump-market
friedreich's ataxia market: https://www.delveinsight.com/report-store/friedreichs-ataxia-market
hay fever conjunctivitis market: https://www.delveinsight.com/report-store/hay-fever-conjunctivitis-market
hip replacement devices market: https://www.delveinsight.com/report-store/hip-reconstruction-devices-market
joint reconstruction devices market: https://www.delveinsight.com/report-store/joint-reconstruction-devices-market
periodontal disease market: https://www.delveinsight.com/report-store/periodontal-disease-market
psoriasis vulgaris market: https://www.delveinsight.com/report-store/psoriasis-vulgaris-market
ranibizumab biosimilars market: https://www.delveinsight.com/report-store/ranibizumab-biosimilars-insight
short bowel syndrome drug market: https://www.delveinsight.com/report-store/short-bowel-syndrome-market
short bowel syndrome market: https://www.delveinsight.com/report-store/short-bowel-syndrome-market
thrombectomy devices market: https://www.delveinsight.com/report-store/thrombectomy-devices-market
type 1 diabetes market: https://www.delveinsight.com/report-store/type-1-diabetes-market
adhd market: https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
attention deficit hyperactivity disorder market: https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
avascular necrosis market: https://www.delveinsight.com/report-store/avascular-necrosis-market
biopsy devices market: https://www.delveinsight.com/report-store/biopsy-devices-market
embolotherapy market: https://www.delveinsight.com/report-store/embolotherapy-market
hydrocephalus treatment market: https://www.delveinsight.com/report-store/hydrocephalus-treatment-market
liquid biospy for cancer diagnostics market: https://www.delveinsight.com/report-store/liquid-biopsy-in-cancer-diagnostics-market
skin grafting devices market: https://www.delveinsight.com/report-store/skin-grafting-devices-market
testicular neoplasm market: https://www.delveinsight.com/report-store/testicular-neoplasm-market
uk healthcare report: https://www.delveinsight.com/report-store/uk-healthcare-outlook-report
vascular access devices market: https://www.delveinsight.com/report-store/vascular-access-device-market
brucellosis market: https://www.delveinsight.com/report-store/brucellosis-market
catheter stabilization devices market: https://www.delveinsight.com/report-store/catheter-stabilization-securement-device-market
dyspepsia market: https://www.delveinsight.com/report-store/functional-dyspepsia-market-share
heart pump devices market: https://www.delveinsight.com/report-store/heart-pump-device-market
phototherapies for psoriasis market: https://www.delveinsight.com/report-store/phototherapies-for-psoriasis-market
radial artery compression device market: https://www.delveinsight.com/report-store/radial-artery-compression-devices-market
sarcopenia market: https://www.delveinsight.com/report-store/sarcopenia-market
shingles market: https://www.delveinsight.com/report-store/shingles-market
surgical site infections market: https://www.delveinsight.com/report-store/surgical-site-infections-ssi-market
venous ulcer market: https://www.delveinsight.com/report-store/venous-leg-ulcer-market
viscosupplementation devices market: https://www.delveinsight.com/report-store/viscosupplementation-devices-market
artificial disc market: https://www.delveinsight.com/report-store/artificial-disc-market
healthcare consulting solutions: https://www.delveinsight.com/consulting
meningococcal meningitis market: https://www.delveinsight.com/report-store/meningococcal-meningitis-market
moderate to severe plaque psoriasis market: https://www.delveinsight.com/blog/us-psoriasis-treatment
pertussis market: https://www.delveinsight.com/report-store/pertussis-market
spinal trauma devices market: https://www.delveinsight.com/report-store/spinal-trauma-devices-market-market
surgical energy instruments market: https://www.delveinsight.com/report-store/surgical-energy-instruments-electrosurgical-devices-market
temporomandibular disorders market: https://www.delveinsight.com/report-store/temporomandibular-disorders-market
transcatheter heart valve replacement devices market: https://www.delveinsight.com/report-store/transcatheter-aortic-valve-replacement-market
urinary catheters market: https://www.delveinsight.com/report-store/urinary-catheters-market
attention deficit hyperactivity disorder adhd market: https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
coronary angioplasty market: https://www.delveinsight.com/report-store/coronary-stents-market-market
nonalcoholic steatohepatitis market: https://www.delveinsight.com/report-store/nonalcoholic-steatohepatitis-nash-market
orthopedic splints device market: https://www.delveinsight.com/report-store/orthopedic-splints-market
perennial allergic rhinitis market: https://www.delveinsight.com/report-store/perennial-allergic-rhinitis-market
pipeline assessment services: https://www.delveinsight.com/consulting/pipeline-assessment-services
schistosomiasis market: https://www.delveinsight.com/report-store/schistosomiasis-market
venous thromboembolism market: https://www.delveinsight.com/report-store/venous-thromboembolism-market
bacterial meningitis market: https://www.delveinsight.com/report-store/meningococcal-meningitis-market
nk cell therapy market: https://www.delveinsight.com/report-store/nk-cell-therapy-market
overactive bladder syndrome market: https://www.delveinsight.com/report-store/overactive-bladder-market
peripheral nerve injuries market: https://www.delveinsight.com/report-store/peripheral-nerve-injuries-market
tendonitis market: https://www.delveinsight.com/report-store/tendonitis-market
endoscopic ultrasound market: https://www.delveinsight.com/report-store/endoscopic-ultrasound-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.